Stephen Eck

Stephen L.
Eck is currently Director at Personalized Medicine Coalition, CirculoGene Theranostics, Inc., and Central Pennsylvania Clinic.
He serves as Chief Medical Officer & SVP-Clinical Development at MacroGenics, Inc. since 2020 and is appointed Chief Medical Officer at Flare Therapeutics, Inc. starting in 2026.
He is also a Trustee at Keck Graduate Institute of Applied Life Sciences.
Formerly, Dr. Eck was President & Chief Executive Officer at Aravive Biologics, Inc. from 2017 to 2018, Independent Director at Luminex Corp.
from 2016 to 2021, Vice President-Translation Medicine at Eli Lilly & Co. from 2007 to 2011, Vice President-Oncology Medical Sciences at Astellas Pharma Global Development, Inc. from 2011 to 2017, and held positions as Vice President-Translational Medicine at Pfizer Inc., Assistant Professor at the University of Pennsylvania, and Chief Medical Officer at Immatics US, Inc. Education includes a doctorate from Harvard University, an undergraduate degree from Kalamazoo College, and a doctorate from the University of Mississippi Medical Center.